×
0 0 0 0 0 0 0 0
Stockreport

Why Geron Corporation Stock Ripped Higher in January [The Motley Fool]

GERON (GERN)  More Company Research Source: The Motley Fool
Last geron earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: geron.com/investors
PDF Geron's jaw-dropping potential appears to be scaring away short-sellers. George Budwell ( TMFGBudwell ) Feb 4, 2018 at 3:36PM What happened Shares of clinical-stage biotech Geron Corporation ( NASDAQ:GERN ) rose by a noteworthy 36.1% in January, according to  S&P Global Market Intelligence  . What drove this breakout?  In late January, Geron's development partner,  Johnson & Johnson ( NYSE:JNJ ) , listed the company's anti-cancer drug, imetelstat, as a top experimental compound during its latest clinical pipeline update. This update, in turn, appears to have sparked a classic short squeeze in Geron's stock.  Image source: Getty Images. So what Geron's stock has been a favorite target of short-sellers for most of the past year. One of the major reasons is a so-called information request from the U.S. Food and Drug Administrati [Read more]

IMPACT SNAPSHOT EVENT TIME: GERN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS